Strategies and Challenges to Myocardial Replacement Therapy
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Summary: Cardiovascular diseases account for the majority of deaths globally and are a significant drain on economic resources. Although heart transplants and left-ventricle assist devices are the solution for some, the best chance for many patients who suffer because of a myocardial infarction, heart failure, or a congenital heart disease may be cell-based regenerative therapies. Such therapies can be divided into two categories: the application of a cell suspension and the implantation of an in vitro engineered tissue construct to the damaged area of the heart. Both strategies have their advantages and challenges, and in this review, we discuss the current state of the art in myocardial regeneration, the challenges to success, and the future direction of the field. Significance: This article outlines the advantages and limitations of the cell injection and patch approaches to cardiac regenerative therapy. If the field is to move forward, some fundamental questions require answers, including the limitations to the use of animal models for human cell-transplantation studies; the best way to measure success in terms of functional improvements, histological integration, electrical coupling, and arrhythmias; and where the cells should be applied for maximal benefit—the epicardium or the myocardium.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence for Cardiomyocyte Renewal in Humans
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., et al. (2009) · Science · doi:10.1126/science.1164680 · Cited by 3,130
Transient Regenerative Potential of the Neonatal Mouse Heart
Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N., & Sadek, H. A. (2011) · Science · doi:10.1126/science.1200708 · Cited by 2,545
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors
Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., & Srivastava, D. (2010) · Cell · doi:10.1016/j.cell.2010.07.002 · Cited by 2,454
Gnecchi, M., He, H., Liang, O. D., Melo, L. G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R. E., Ingwall, J. S., et al. (2005) · Nature Medicine · doi:10.1038/nm0405-367 · Cited by 1,677
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389
O'Hara, T., Virág, L., Varró, A., & Rudy, Y. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002061 · Cited by 1,196
Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., & Keller, G. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.008 · Cited by 1,159
Functional screening identifies miRNAs inducing cardiac regeneration
Eulalio, A., Mano, M., Ferro, M. D., Zentilin, L., Sinagra, G., Zacchigna, S., & Giacca, M. (2012) · Nature · doi:10.1038/nature11739 · Cited by 1,029
Biowire: a platform for maturation of human pluripotent stem cell–derived cardiomyocytes
Nunes, S. S., Miklas, J. W., Liu, J., Aschar-Sobbi, R., Xiao, Y., Zhang, B., Jiang, J., Massé, S., Gagliardi, M., Hsieh, A., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2524 · Cited by 952
Self-citationEngineering Adolescence: Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes
Yang, X., Pabon, L., & Murry, C. E. (2014) · Circulation Research · doi:10.1161/circresaha.114.300558 · Cited by 939
Research works printed but not linked: 76
- Mendis, 2015, Organizational update: The World Health Organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease, Stroke, 46, e121, 10.1161/STROKEAHA.115.008097 · DOI · Paper page
- Reinecke, 2008, Cardiogenic differentiation and transdifferentiation of progenitor cells, Circ Res, 103, 1058, 10.1161/CIRCRESAHA.108.180588 · DOI
- Tous, 2011, Injectable acellular hydrogels for cardiac repair, J Cardiovasc Transl Res, 4, 528, 10.1007/s12265-011-9291-1 · DOI · Paper page
- Chong, 2014, Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts, Nature, 510, 273, 10.1038/nature13233 · DOI · Paper page
- Jawad, 2007, Myocardial tissue engineering: A review, J Tissue Eng Regen Med, 1, 327, 10.1002/term.46 · DOI · Paper page
- Sirish, 2012, MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts, J Mol Cell Cardiol, 52, 264, 10.1016/j.yjmcc.2011.10.012 · DOI
- Porrello, 2011, MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes, Circ Res, 109, 670, 10.1161/CIRCRESAHA.111.248880 · DOI · Paper page
- Hullinger, 2012, Inhibition of miR-15 protects against cardiac ischemic injury, Circ Res, 110, 71, 10.1161/CIRCRESAHA.111.244442 · DOI · Paper page
- van Rooij, 2012, MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles, Nat Rev Drug Discov, 11, 860, 10.1038/nrd3864 · DOI · Paper page
- Chimenti, 2010, Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice, Circ Res, 106, 971, 10.1161/CIRCRESAHA.109.210682 · DOI · Paper page
- Malliaras, 2014, Intracoronary cardiosphere-derived cells after myocardial infarction: Evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction), J Am Coll Cardiol, 63, 110, 10.1016/j.jacc.2013.08.724 · DOI · Paper page
- Ebert, 2015, Reprogramming and transdifferentiation for cardiovascular development and regenerative medicine: Where do we stand?, EMBO Mol Med, 7, 1090, 10.15252/emmm.201504395 · DOI
- Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
- Zhang, 2009, Functional cardiomyocytes derived from human induced pluripotent stem cells, Circ Res, 104, e30, 10.1161/CIRCRESAHA.108.192237 · DOI · Paper page
- Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
- Nichols, 2009, Naive and primed pluripotent states, Cell Stem Cell, 4, 487, 10.1016/j.stem.2009.05.015 · DOI · Paper page
- Gafni, 2013, Derivation of novel human ground state naive pluripotent stem cells, Nature, 504, 282, 10.1038/nature12745 · DOI · Paper page
- Honda, 2013, Naive-like conversion overcomes the limited differentiation capacity of induced pluripotent stem cells, J Biol Chem, 288, 26157, 10.1074/jbc.M113.502492 · DOI
- Kehat, 2001, Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes, J Clin Invest, 108, 407, 10.1172/JCI200112131 · DOI
- Mummery, 2007, Cardiomyocytes from human and mouse embryonic stem cells, Methods Mol Med, 140, 249, 10.1007/978-1-59745-443-8_14 · DOI
- Burridge, 2011, A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability, PLoS One, 6, e18293, 10.1371/journal.pone.0018293 · DOI · Paper page
- Paige, 2010, Endogenous Wnt/beta-catenin signaling is required for cardiac differentiation in human embryonic stem cells, PLoS One, 5, e11134, 10.1371/journal.pone.0011134 · DOI · Paper page
- Zhang, 2012, Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method, Circ Res, 111, 1125, 10.1161/CIRCRESAHA.112.273144 · DOI · Paper page
- Lian, 2013, Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions, Nat Protoc, 8, 162, 10.1038/nprot.2012.150 · DOI · Paper page
- Synnergren, 2012, Global transcriptional profiling reveals similarities and differences between human stem cell-derived cardiomyocyte clusters and heart tissue, Physiol Genomics, 44, 245, 10.1152/physiolgenomics.00118.2011 · DOI · Paper page
- Mummery, 2003, Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells, Circulation, 107, 2733, 10.1161/01.CIR.0000068356.38592.68 · DOI · Paper page
- Robertson, 2013, Concise review: Maturation phases of human pluripotent stem cell-derived cardiomyocytes, Stem Cells, 31, 829, 10.1002/stem.1331 · DOI · Paper page
- Mummery, 2012, Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: A methods overview, Circ Res, 111, 344, 10.1161/CIRCRESAHA.110.227512 · DOI · Paper page
- Pillekamp, 2012, Contractile properties of early human embryonic stem cell-derived cardiomyocytes: Beta-adrenergic stimulation induces positive chronotropy and lusitropy but not inotropy, Stem Cells Dev, 21, 2111, 10.1089/scd.2011.0312 · DOI
- Poon, 2011, Human pluripotent stem cell-based approaches for myocardial repair: From the electrophysiological perspective, Mol Pharm, 8, 1495, 10.1021/mp2002363 · DOI
- Itzhaki, 2006, Calcium handling in embryonic stem cell-derived cardiac myocytes: Of mice and men, Ann N Y Acad Sci, 1080, 207, 10.1196/annals.1380.017 · DOI
- Lee, 2013, Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies, Nat Med, 19, 998, 10.1038/nm.3267 · DOI · Paper page
- Efe, 2011, Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy, Nat Cell Biol, 13, 215, 10.1038/ncb2164 · DOI · Paper page
- Qian, 2012, In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes, Nature, 485, 593, 10.1038/nature11044 · DOI · Paper page
- Islas, 2012, Transcription factors ETS2 and MESP1 transdifferentiate human dermal fibroblasts into cardiac progenitors, Proc Natl Acad Sci USA, 109, 13016, 10.1073/pnas.1120299109 · DOI · Paper page
- Fu, 2013, Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state, Stem Cell Rep, 1, 235, 10.1016/j.stemcr.2013.07.005 · DOI · Paper page
- Nam, 2014, Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors, Development, 141, 4267, 10.1242/dev.114025 · DOI
- Wada, 2013, Induction of human cardiomyocyte-like cells from fibroblasts by defined factors, Proc Natl Acad Sci USA, 110, 12667, 10.1073/pnas.1304053110 · DOI · Paper page
- Sanganalmath, 2013, Cell therapy for heart failure: A comprehensive overview of experimental and clinical studies, current challenges, and future directions, Circ Res, 113, 810, 10.1161/CIRCRESAHA.113.300219 · DOI · Paper page
- Zangi, 2013, Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction, Nat Biotechnol, 31, 898, 10.1038/nbt.2682 · DOI · Paper page
- Smart, 2011, De novo cardiomyocytes from within the activated adult heart after injury, Nature, 474, 640, 10.1038/nature10188 · DOI · Paper page
- Chung, 2015, Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: The STOP-HF randomized Phase II trial, Eur Heart J, 36, 2228, 10.1093/eurheartj/ehv254 · DOI · Paper page
- Korf-Klingebiel, 2015, Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction, Nat Med, 21, 140, 10.1038/nm.3778 · DOI · Paper page
- Lipinski, 2007, Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials, J Am Coll Cardiol, 50, 1761, 10.1016/j.jacc.2007.07.041 · DOI · Paper page
- Menasché, 2015, Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: First clinical case report, Eur Heart J, 36, 2011, 10.1093/eurheartj/ehv189 · DOI · Paper page
- Prowse, 2014, Transforming the promise of pluripotent stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials, Can J Cardiol, 30, 1335, 10.1016/j.cjca.2014.08.005 · DOI
- Ye, 2014, Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells [published correction appears in Cell Stem Cell 2015 Jan 8;16:102], Cell Stem Cell, 15, 750, 10.1016/j.stem.2014.11.009 · DOI · Paper page
- Laflamme, 2007, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts, Nat Biotechnol, 25, 1015, 10.1038/nbt1327 · DOI · Paper page
- van Laake, 2008, Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents, Circ Res, 102, 1008, 10.1161/CIRCRESAHA.108.175505 · DOI · Paper page
- Gepstein, 2010, In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies [published correction appears in Stem Cells 2011 Sep;29(9):1475], Stem Cells, 28, 2151, 10.1002/stem.545 · DOI
- Shiba, 2012, Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts, Nature, 489, 322, 10.1038/nature11317 · DOI · Paper page
- Kehat, 2004, Electromechanical integration of cardiomyocytes derived from human embryonic stem cells, Nat Biotechnol, 22, 1282, 10.1038/nbt1014 · DOI · Paper page
- Schram, 2002, Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function, Circ Res, 90, 939, 10.1161/01.RES.0000018627.89528.6F · DOI · Paper page
- Hirt, 2014, Cardiac tissue engineering: State of the art, Circ Res, 114, 354, 10.1161/CIRCRESAHA.114.300522 · DOI · Paper page
- Sun, 2015, Overview of hydrogel-based strategies for application in cardiac tissue regeneration, Biomed Mater, 10, 034005, 10.1088/1748-6041/10/3/034005 · DOI
- Reis, 2016, Biomaterials in myocardial tissue engineering, J Tissue Eng Regen Med, 10, 11, 10.1002/term.1944 · DOI · Paper page
- Zhang, 2011, Micro- and nanotechnology in cardiovascular tissue engineering, Nanotechnology, 22, 494003, 10.1088/0957-4484/22/49/494003 · DOI
- Park, 2011, The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructs, Biomaterials, 32, 1856, 10.1016/j.biomaterials.2010.11.032 · DOI
- Nawroth, 2012, A tissue-engineered jellyfish with biomimetic propulsion, Nat Biotechnol, 30, 792, 10.1038/nbt.2269 · DOI · Paper page
- Liau, 2011, Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function, Biomaterials, 32, 9180, 10.1016/j.biomaterials.2011.08.050 · DOI · Paper page
- Zimmermann, 2006, Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts, Nat Med, 12, 452, 10.1038/nm1394 · DOI · Paper page
- Naito, 2006, Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle, Circulation, 114, I72
- Riegler, 2014, Cardiac tissue slice transplantation as a model to assess tissue-engineered graft thickness, survival, and function, Circulation, 130, S77
- Sun, 2016, Vascularization strategies of engineered tissues and their application in cardiac regeneration, Adv Drug Deliv Rev, 96, 183, 10.1016/j.addr.2015.06.001 · DOI
- Mohanty, 2015, Fabrication of scalable and structured tissue engineering scaffolds using water dissolvable sacrificial 3D printed moulds, Mater Sci Eng C, 55, 569, 10.1016/j.msec.2015.06.002 · DOI · Paper page
- Zhao, 2014, In vitro vascularization of a combined system based on a 3D printing technique, J Tissue Eng Regen Med
- Masuda, 2016, Three-dimensional cardiac tissue fabrication based on cell sheet technology, Adv Drug Deliv Rev, 96, 103, 10.1016/j.addr.2015.05.002 · DOI
- Zhang, 2015, Platform technology for scalable assembly of instantaneously functional mosaic tissues, Sci Adv, 1, e1500423, 10.1126/sciadv.1500423 · DOI
- Gerbin, 2015, Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts, PLoS One, 10, e0131446, 10.1371/journal.pone.0131446 · DOI · Paper page
- Mandarim-de-Lacerda, 2000, Numerical density of cardiomyocytes in chronic nitric oxide synthesis inhibition, Pathobiology, 68, 36, 10.1159/000028113 · DOI
- Wei, 2015, Epicardial FSTL1 reconstitution regenerates the adult mammalian heart, Nature, 525, 479, 10.1038/nature15372 · DOI · Paper page
- Smart, 2012, Myocardial regeneration: Expanding the repertoire of thymosin β4 in the ischemic heart, Ann N Y Acad Sci, 1269, 92, 10.1111/j.1749-6632.2012.06708.x · DOI
- Bett, 2013, Electronic “expression” of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells, Heart Rhythm, 10, 1903, 10.1016/j.hrthm.2013.09.061 · DOI
- Fu, 2011, Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes, PLoS One, 6, e27417, 10.1371/journal.pone.0027417 · DOI · Paper page
- Lin, 2012, Partitioning the heart: Mechanisms of cardiac septation and valve development, Development, 139, 3277, 10.1242/dev.063495 · DOI · Paper page
- Arnal-Pastor, 2013, Regenerative Medicine and Tissue Engineering
Cited by
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
McNally, E. M., & Mestroni, L. (2017) · Circulation Research · doi:10.1161/circresaha.116.309396 · Cited by 786
“Various studies and clinical trials have tested cardiac progenitor cells, bone marrow–derived stem cells, and pluripotent stem cells.(164) Frustratingly, these clinical interventions demonstrated safety but often failed to prove functional improvement.”
Ruan, J.-L., Tulloch, N. L., Razumova, M. V., Saiget, M., Muskheli, V., Pabon, L., Reinecke, H., Regnier, M., & Murry, C. E. (2016) · Circulation · doi:10.1161/circulationaha.114.014998 · Cited by 467
A tissue-engineered scale model of the heart ventricle
MacQueen, L. A., Sheehy, S. P., Chantre, C. O., Zimmerman, J. F., Pasqualini, F. S., Liu, X., Goss, J. A., Campbell, P. H., Gonzalez, G. M., Park, S.-J., et al. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0271-5 · Cited by 227
Metadata
- Authors
- Feric, N. T., & Radisic, M.
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-03-01
- Volume
- 5
- Issue
- 4
- Pages
- 410-416
- ISSN
- 2157-6564 (ISSN-L)
- 2157-6580
- OpenAlex
- W2291043294
- Cited by
- 47
- References
- 17
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- Canadian Institutes of Health Research Operating (MOP-126027)
- Natural Sciences and Engineering Research Council of Canada Discovery (326982-10)
- National Institutes of Health (HL076485)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Strategies and Challenges to Myocardial Replacement Therapy. https://app.cochat.ai/papers/10.5966/sctm.2015-0288
- The paper
- Feric, N. T., & Radisic, M. (2016). Strategies and Challenges to Myocardial Replacement Therapy. Stem Cells Translational Medicine. https://doi.org/10.5966/sctm.2015-0288
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.